Thrombosis
Clinical
PE is rare in patients presenting to the ED with syncope
Clinical question: What is the prevalence of pulmonary embolism (PE) in patients presenting to the ED with syncope?
Clinical
Pulmonary Embolism Rule-Out Criteria Strategy is noninferior when clinical probability is low
Can low probability pulmonary embolism (PE) be safely excluded using the Pulmonary Embolism Rule-Out Criteria?
Clinical
After initial rivaroxaban, aspirin is noninferior to rivaroxaban for thromboprophylaxis following joint arthroplasty
Is aspirin as effective as rivaroxaban at reducing rates of symptomatic venous thromboembolism (VTE) after hip or knee arthroplasty?
News
DOACs’ safety affirmed in real-world setting
Direct oral anticoagulants were linked with lower bleeding risk, regardless of reason for use. One shone brightest.
Clinical
ICH: Recent NOAC use associated with lower risk of in-hospital mortality, compared with warfarin
Among patients presenting with an intracerebral hemorrhage (ICH), what is the association between recent anticoagulant use and in-hospital...
News
New look at ATLAS suggests rivaroxaban may still have role in ACS
A reanalysis of the ATLAS ACS 2-TIMI 51 trial separated fatal and nonfatal events.
Clinical
Myeloproliferative neoplasms increase risk for arterial and venous thrombosis
What are the risks for arterial and venous thrombosis in patients with myeloproliferative neoplasms (MPNs)?
News
RBC transfusions with surgery may increase VTE risk
Stricter blood management practices and VTE prophylaxis may be needed if the study findings are confirmed.
News
DOAC’s edge over warfarin fades with low adherence
BOSTON –
Clinical
Skip the catheter-directed thrombolytics
Does the addition of catheter-directed thrombolysis to standard therapy with anticoagulation reduce the risk of the postthrombotic syndrome in...